Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world byimproving access to proven treatments for various diseases.

$3.8B

Market Cap • 12/26/2024

2018

(6 years)
Founded

2022

(2 years ago)
IPO

NASDAQ

Listing Exchange
Flag of LU

Luxembourg

Headquarters